Welcome
The CTRND is an innovative, multidisciplinary research center focused on the discovery, development and evaluation of future treatments and diagnostics for degenerative central nervous system conditions.
Our Mission
The CTRND’s mission is to discover, develop and evaluate future treatments and diagnostics for degenerative central nervous system conditions including Alzheimer’s disease, Parkinson’s disease, stroke and other neurodegenerative brain disorders.
Recent News
Dr. Moehle and Gallardo Featured at Biomedical…
In a warm and collegial gathering Sept. 21, 50 second-year doctoral students from the University of Florida College of Medicine Graduate Program in…
Congratulations to Dr. Chakrabarty!
For her selection as chair of a National Institute of Aging study section: “Career Development Facilitating the Transition to Independence”
Congratulations to Mackenzie Bolen for being…
MacKenzie Bolen, a graduate student in Dr. Malu Tansey’s lab, was awarded a grant for her research through the Bryan W. Robinson Endowment.
College Calendar
Upcoming Events
-
Jan 08
-
CTRND Faculty Meeting
9:30am to 10:30am
-
-
Feb 05
-
CTRND Data Seminar
9:30am to 10:30am
-
-
Mar 04
-
CTRND Faculty Meeting
9:30am to 10:30am
-
-
Mar 05
-
AD/PD 2024
Lisbon, Portugal
All Day
-
-
Mar 06
-
AD/PD 2024
Lisbon, Portugal
All Day
-
1Florida ADRC
Deadline: Developmental Project Grants
November 18 at 5 pm
Research proposals can span the spectrum of Alzheimer’s disease (AD) and AD related disorders -ranging from basic, clinical, translational, and health care outcomes and policy research, with particular attention given to novel approaches. Research projects may involve humans, data mining, model systems, preclinical therapeutic development or in vitro studies. Clinical trials are not allowed. Though we will not have a formal LOI process, we strongly encourage prospective applicants to discuss both eligibility and the project with 1Florida ADRC investigators and the director (tgolde@ufl.edu) prior to submission. Total direct budgets up to $100,000/yr will be considered.
